insights_auto
Why is INO down ၃.၀၂%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၄၃ US$
arrow_downward
-၃.၀၂%(-၀.၀၄၅) 1D
နို ၁၂, GMT-၅ ၀၉:၅၅:၄၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၄၄ US$
High
၁.၄၆ US$
Low
၁.၃၃ US$
Mkt. cap
၂၆.၇၀ ကုဋေ
Avg. vol.
၁.၉၁ ကုဋေ
Volume
၈.၉၇ သိန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၁.၁၇ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၄၄ US$
High
၁.၄၆ US$
Low
၁.၃၃ US$
Mkt. cap
၂၆.၇၀ ကုဋေ
Avg. vol.
၁.၉၁ ကုဋေ
Volume
၈.၉၇ သိန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၆ US$
EPS
-၁.၁၇ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlights: FDA Approval, Commercial ...
GuruFocus
·
ပြီးခဲ့သည့် ၂၃ နာရီ
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
TradingView
·
ပြီးခဲ့သည့် ၁ ရက်
Key facts: INO Extends Runway; 2027 Launch; Data, Partner Search
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc